Tech Center 1600 • Art Units: 1671 1685
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17270072 | SYSTEMS AND METHODS FOR PROVIDING CONTAINER BASED MEDICATION DOSE GUIDANCE TO TREAT DIABETES | Final Rejection | Novo Nordisk A/S |
| 17120545 | SOCIAL DISTANCING OPTIMIZATION | Final Rejection | International Business Machines Corporation |
| 17274155 | METHOD TO DETERMINE IF A CIRCULATING FETAL CELL ISOLATED FROM A PREGNANT MOTHER IS FROM EITHER THE CURRENT OR A HISTORICAL PREGNANCY | Non-Final OA | Illumina Cambridge Limited |
| 17275653 | METHOD AND APPARATUS FOR DETECTING COPY NUMBER VARIATIONS IN A GENOME | Non-Final OA | The Jackson Laboratory |
| 17313707 | PATHOGEN TESTING | Non-Final OA | BATTELLE MEMORIAL INSTITUTE |
| 17346060 | MONITORING MUTATIONS USING PRIOR KNOWLEDGE OF VARIANTS | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 18096449 | Method of Detecting Viral Infection Using Primary and Secondary Hematology Parameters | Non-Final OA | Beckman Coulter, Inc. |
| 18753906 | DETERMINING PHENOMIC RELATIONSHIPS BETWEEN COMPOUNDS AND CELL PERTURBATIONS UTILIZING MACHINE LEARNING MODELS | Non-Final OA | Recursion Pharmaceuticals, Inc. |
| 16903231 | CANCER SCREENING USING METHYLATION OF CPG ISLANDS | Final Rejection | The Chinese University of Hong Kong |
| 18659964 | SYSTEMS AND METHODS FOR GENERATIVE DESIGN OF CUSTOM BIOLOGICS | Final Rejection | Pythia Labs, Inc. |
| 18544214 | METHODS AND SYSTEMS FOR THERAPY MONITORING AND TRIAL DESIGN | Final Rejection | Scipher Medicine Corporation |
| 17930460 | COMPOSITIONS AND METHODS FOR DIAGNOSING COLORECTAL CANCER | Non-Final OA | GeneGenieDx Corporation |
| 17263680 | METHOD OF DIAGNOSIS OF LIVER STEATOSIS | Non-Final OA | ASSISTANCE PUBLIQUE -HÔPITAUX DE PARIS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy